within Pharmacolibrary.Drugs.B_BloodAndBloodFormingOrgans.B03B_VitaminB12AndFolicAcid.B03BA53_HydroxocobalaminCombinations;

model HydroxocobalaminCombinations
  extends Pharmacolibrary.Drugs.ATC.B.B03BA53;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>B03BA53</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Hydroxocobalamin is a form of vitamin B12, used primarily for the treatment of vitamin B12 deficiency and as an antidote to cyanide poisoning. In combination products (ATC code B03BA53), it may be co-formulated with other vitamins or minerals for parenteral supplementation, but such combinations are not widely approved or available in all countries.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters for hydroxocobalamin, combinations (ATC B03BA53) have not been specifically published. The following estimates are based on the pharmacokinetics of hydroxocobalamin monotherapy in healthy adults after intravenous administration.</p><h4>References</h4><ol><li><p>Thompson, JP, &amp; Marrs, TC (2012). Hydroxocobalamin in cyanide poisoning. <i>Clinical toxicology (Philadelphia, Pa.)</i> 50(10) 875–885. DOI:<a href=&quot;https://doi.org/10.3109/15563650.2012.742197&quot;>10.3109/15563650.2012.742197</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/23163594/&quot;>https://pubmed.ncbi.nlm.nih.gov/23163594</a></p></li><li><p>Shepherd, G, &amp; Velez, LI (2008). Role of hydroxocobalamin in acute cyanide poisoning. <i>The Annals of pharmacotherapy</i> 42(5) 661–669. DOI:<a href=&quot;https://doi.org/10.1345/aph.1K559&quot;>10.1345/aph.1K559</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/18397973/&quot;>https://pubmed.ncbi.nlm.nih.gov/18397973</a></p></li><li><p>Forsyth, JC, et al., &amp; Hall, AH (1993). Hydroxocobalamin as a cyanide antidote: safety, efficacy and pharmacokinetics in heavily smoking normal volunteers. <i>Journal of toxicology. Clinical toxicology</i> 31(2) 277–294. DOI:<a href=&quot;https://doi.org/10.3109/15563659309000395&quot;>10.3109/15563659309000395</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8492341/&quot;>https://pubmed.ncbi.nlm.nih.gov/8492341</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end HydroxocobalaminCombinations;
